1. Home
  2. NVCT vs GAUZ Comparison

NVCT vs GAUZ Comparison

Compare NVCT & GAUZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVCT
  • GAUZ
  • Stock Information
  • Founded
  • NVCT 2020
  • GAUZ 2009
  • Country
  • NVCT United States
  • GAUZ Israel
  • Employees
  • NVCT N/A
  • GAUZ N/A
  • Industry
  • NVCT Medicinal Chemicals and Botanical Products
  • GAUZ Industrial Machinery/Components
  • Sector
  • NVCT Health Care
  • GAUZ Miscellaneous
  • Exchange
  • NVCT Nasdaq
  • GAUZ Nasdaq
  • Market Cap
  • NVCT 184.9M
  • GAUZ 152.3M
  • IPO Year
  • NVCT 2022
  • GAUZ 2024
  • Fundamental
  • Price
  • NVCT $7.78
  • GAUZ $7.32
  • Analyst Decision
  • NVCT Strong Buy
  • GAUZ Strong Buy
  • Analyst Count
  • NVCT 3
  • GAUZ 3
  • Target Price
  • NVCT $17.00
  • GAUZ $14.67
  • AVG Volume (30 Days)
  • NVCT 265.7K
  • GAUZ 565.7K
  • Earning Date
  • NVCT 08-05-2025
  • GAUZ 08-13-2025
  • Dividend Yield
  • NVCT N/A
  • GAUZ N/A
  • EPS Growth
  • NVCT N/A
  • GAUZ N/A
  • EPS
  • NVCT N/A
  • GAUZ N/A
  • Revenue
  • NVCT N/A
  • GAUZ $101,165,000.00
  • Revenue This Year
  • NVCT N/A
  • GAUZ $28.49
  • Revenue Next Year
  • NVCT N/A
  • GAUZ $47.77
  • P/E Ratio
  • NVCT N/A
  • GAUZ N/A
  • Revenue Growth
  • NVCT N/A
  • GAUZ 18.63
  • 52 Week Low
  • NVCT $4.44
  • GAUZ $5.50
  • 52 Week High
  • NVCT $11.80
  • GAUZ $13.00
  • Technical
  • Relative Strength Index (RSI)
  • NVCT 44.12
  • GAUZ N/A
  • Support Level
  • NVCT $7.70
  • GAUZ N/A
  • Resistance Level
  • NVCT $8.24
  • GAUZ N/A
  • Average True Range (ATR)
  • NVCT 0.44
  • GAUZ 0.00
  • MACD
  • NVCT 0.03
  • GAUZ 0.00
  • Stochastic Oscillator
  • NVCT 27.52
  • GAUZ 0.00

About NVCT Nuvectis Pharma Inc.

Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of innovative precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.

About GAUZ Gauzy Ltd. Ordinary Shares

Gauzy Ltd is a fully integrated light and vision control company. Its products include suspended particle device and liquid crystal materials for smart glass applications and AI-powered driver assistance systems, or ADAS, solutions including camera monitoring systems. The company's operating segments are Architecture, Automotive, Safety tech, and Aeronautics. Maximum revenue is generated from its Safety tech segment, which focuses on sales of driver assistance systems for buses, coaches, recreational vehicles, and specific vehicles, such as camera and motion sensor systems, smart mirrors, and safety doors. Geographically, it derives maximum revenue from other European countries (excluding France), followed by the United States, France, Asia, Israel, and other regions.

Share on Social Networks: